ASX:ANP (Australia)  
Antisense Therapeutics Ltd logo

Antisense Therapeutics Ltd

A$ 0.09 (-4.44%) Nov 30
P/E:
At Loss
P/B:
2.81
Market Cap:
A$ 60.21M ($ 40.49M)
Enterprise V:
A$ 41.21M ($ 27.71M)
Volume:
268.02K
Avg Vol (2M):
377.46K
Also Trade In:
Volume:
268.02K
Market Cap A$:
60.21M
Market Cap $:
40.49M
PE Ratio:
At Loss
Avg Vol (2-Month):
377.46K
Enterprise Value A$:
41.21M
Enterprise Value $:
27.71M
PB Ratio:
2.81
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 84.73
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 29.79
9-Day RSI 37.98
14-Day RSI 42.51
6-1 Month Momentum % -23.81
12-1 Month Momentum % -60.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.14
Quick Ratio 19.14
Cash Ratio 16.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.8

Profitability Rank

Name Current Vs Industry Vs History
ROE % -34.34
ROA % -32
ROIC % -488.62
ROC (Joel Greenblatt) % -1725.85
ROCE % -44.49
Years of Profitability over Past 10-Year 1

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.009
Beta 0.49
Volatility % 43.41
14-Day RSI 42.51
14-Day ATR (A$) 0.005983
20-Day SMA (A$) 0.0968
12-1 Month Momentum % -60.98
52-Week Range (A$) 0.073 - 0.21
Shares Outstanding (Mil) 669.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Antisense Therapeutics Ltd Filings

Document Form Filing Date
No Filing Data

Antisense Therapeutics Ltd Analysis

Share your research